Navigation Links
BodySculpt(TM) Leads FDA Approval of BodyTite(TM) with Largest Number of Documented Study Cases
Date:9/16/2009

NEW YORK, Sept. 16 /PRNewswire/ -- The plastic surgeons at BodySculpt(TM) are revolutionizing the latest techniques in liposuction -- one radio-frequency wave at a time. Since being selected by Invasix to head the FDA approval studies of BodyTite(TM), BodySculpt(TM) has lead the industry in its number of case studies and field research. The latest device in body-contouring procedures, BodyTite(TM) utilizes radio-frequency assisted liposuction (RFAL) technology. With the direction of board certified BodySculpt(TM) Surgical Director Dr. Christopher Chia BodySculpt(TM) is the first team of surgeons in the New York area to use BodyTite(TM) and is the leading authority in RFAL and its introduction to the world of plastic surgery.

BodyTite(TM) is the most compact and ergonomic, energy-assisted liposuction device in the world, in addition to being powerful, minimally invasive and safe. BodyTite(TM) liposuction procedures not only produce successful fat removal with less downtime, but also improve patient safety and comfort.

After conducting several case studies on women with postpartum body insecurities, the plastic surgeons at BodySculpt(TM) have even deemed it as the "virtual no scar tummy-tuck". The RFAL technology induces simultaneous tissue liquefaction, blood vessel coagulation, and heating of the skin, which results in optimal soft tissue contraction and skin tightening. This makes the procedure ideal for postpartum patients or others with compromised skin laxity, such as those who have just experienced extreme weight loss.

Having conducted the largest number of study cases of the procedure in the US, the impressive findings of the doctors at BodySculpt(TM) will aide in determining industry-wide effectiveness and safety standards of BodyTite(TM) once approved by the FDA. Results, reactions, and conclusions thus far have been extremely positive and successful- great news for the FDA approval process, potential patients and surgeons alike.


'/>"/>
SOURCE BodySculpt
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. San Ramon HR Firm Leads Response to New Cal/OSHA ATD Law
2. Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder
3. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
4. Pharmaleads Lead Candidate for Pain, PL37, Enters Phase I
5. Discovery Leads to Earlier Diagnosis of Type 1 Diabetes
6. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
7. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
8. ISTA Pharmaceuticals Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
9. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
10. ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis
11. WorldHeart Receives US Clinical Study Approval for the Levacor(TM) VAD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... IRVING, Texas , Sept. 7, 2017 /PRNewswire/ ... molecular science focused on fulfilling the promise of ... that further validate the benefits of its molecular ... Each study utilized comprehensive genomic profiling plus (CGP+) ... each individual patient,s tumor on a molecular level, ...
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: LLY ) ... and lasmiditan, two investigational treatments for migraine, at the ... place Sept. 7-10 in Vancouver . ... from an open-label study evaluating the safety and effectiveness ... mg) for the prevention of migraine. Galcanezumab is a ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... Ecocor , ... Richard Pedranti Architect (RPA), a full-service architecture firm focusing on sustainable design, ... Line of Model Homes . Independently, Ecocor and RPA have extensive experience with ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... inaugural SABRE Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student ... MS in Educational Leadership and Administration at St. Thomas University in Miami, Florida, ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Cursed with a Curse: ... tithe, and the freedom experienced when breaking free from this misconception. “Cursed with ... M. Harrison. , Published by Christian Faith Publishing, Lysa M. Harrison’s new book ...
(Date:9/22/2017)... ... , ... "Success Files," a short- and long-form documentary style ... disease estimated to affect the lives of more than 5 million Americans living ... leading voice in the fight for cure and research into the disease, its ...
(Date:9/22/2017)... ... 2017 , ... “Letters From Home”: a moving compilation of letters that ... God. “Letters From Home” is the creation of published author, John Allred, a passionate ... Jerry Savelle Ministries International, who has traveled and ministered on four continents. , “It ...
Breaking Medicine News(10 mins):